219 related articles for article (PubMed ID: 26241451)
1. Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.
Reyes M; Rojas-Alcayaga G; Maturana A; Aitken JP; Rojas C; Ortega AV
Med Oral Patol Oral Cir Bucal; 2015 Sep; 20(5):e540-6. PubMed ID: 26241451
[TBL] [Abstract][Full Text] [Related]
2. beta- and gamma-catenin expression in oral dysplasia.
Lo Muzio L; Lo Russo L; Falaschini S; Ciavarella D; Pentenero M; Arduino P; Favia G; Maiorano E; Rubini C; Pieramici T; Gandolfo S
Oral Oncol; 2009 Jun; 45(6):501-4. PubMed ID: 18715817
[TBL] [Abstract][Full Text] [Related]
3. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
4. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
5. β-catenin expression in areca quid chewing-associated oral squamous cell carcinomas and upregulated by arecoline in human oral epithelial cells.
Lee SS; Tsai CH; Tsai LL; Chou MC; Chou MY; Chang YC
J Formos Med Assoc; 2012 Apr; 111(4):194-200. PubMed ID: 22526207
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia.
Ishida K; Ito S; Wada N; Deguchi H; Hata T; Hosoda M; Nohno T
Mol Cancer; 2007 Oct; 6():62. PubMed ID: 17922924
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
10. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
Prgomet Z; Andersson T; Lindberg P
Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor κB and cyclooxygenase-2 immunoexpression in oral dysplasia and oral squamous cell carcinoma.
Pontes HA; Pontes FS; Fonseca FP; de Carvalho PL; Pereira EM; de Abreu MC; de Freitas Silva BS; dos Santos Pinto D
Ann Diagn Pathol; 2013 Feb; 17(1):45-50. PubMed ID: 22818026
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
13. Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
de Carvalho Fraga CA; Farias LC; de Oliveira MV; Domingos PL; Pereira CS; Silva TF; Roy A; Gomez RS; de Paula AM; Guimarães AL
Pathol Res Pract; 2014 Dec; 210(12):959-64. PubMed ID: 25441661
[TBL] [Abstract][Full Text] [Related]
14. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.
Chen YK; Huang AH; Cheng PH; Yang SH; Lin LM
Clin Oral Investig; 2013 Apr; 17(3):921-32. PubMed ID: 22669485
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
19. Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma.
Fujii M; Katase N; Lefeuvre M; Gunduz M; Buery RR; Tamamura R; Tsujigiwa H; Nagatsuka H
J Mol Histol; 2011 Dec; 42(6):499-504. PubMed ID: 21932035
[TBL] [Abstract][Full Text] [Related]
20. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
Zargaran M
Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
